Mechanistically, RKIP acts primarily as tumour suppressor also in melanoma, in fact, its silencing results in increased expression of various oncogenes (KIT, BCL3, MAF, MYC, MYCL, HOXA9, CDC25B, and PIM1), most of which are associated with the transcription factor NANOG. This evidence concerns the gene PEBP1 and neoplasm.